Andreas Lechner (A Lechner)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Topics

Early Breast Cancer

Insulin Resistance

Randomized Controlled Trial

Top Venues

BMJ open diabetes research & care

Diabetic medicine : a journal of the British Diabetic Association

Physiological reports

This page only lists publications with an associated author ORCID identifier.

Publications

Lorena Wanger, Christina Gar, Michaela Rippl, Stefanie Kern-Matschilles, Anne Potzel, Stefanie Haschka, Jochen Seissler, Nina Hesse, Andreas Lechner
Function outperforms morphology in the assessment of muscular contribution to insulin sensitivity in premenopausal women. Diabetes & vascular disease research 19 (1) (2022)
Stefanie J Haschka, Christina Gar, Vanessa Sacco, Friederike Banning, Uta Ferrari, Ines Freibothe, Stefanie Kern-Matschilles, Anne L Potzel, Barbara Rauch, Louise U Fueessl, Mandy Meisel, Irina Benz, Cornelia Then, Jochen Seissler, Andreas Lechner
Pre-diabetes, diabetes and fluctuations of glucose tolerance after gestational diabetes mellitus: 5-year follow-up of a contemporary, prospective study in Germany. BMJ open diabetes research & care 10 (2) (2022)
Anne Lotte Potzel, Christina Gar, Friederike Banning, Vanessa Sacco, Andreas Fritsche, Louise Fritsche, Karsten Müssig, Laura Dauben, Jochen Seissler, Andreas Lechner
A novel smartphone app to change risk behaviors of women after gestational diabetes: A randomized controlled trial. PloS one 17 (4) (2022)
Julia Keilen, Christina Gar, Marietta Rottenkolber, Louise U Fueessl, Anna T Joseph, Rika Draenert, Jochen Seissler, Andreas Lechner
No association of natural killer cell number and function in peripheral blood with overweight/obesity and metabolic syndrome in a cohort of young women. Physiological reports 10 (4) (2022)
Anne Lotte Potzel, Christina Gar, Jochen Seissler, Andreas Lechner
A Smartphone App (TRIANGLE) to Change Cardiometabolic Risk Behaviors in Women Following Gestational Diabetes Mellitus: Intervention Mapping Approach. JMIR mHealth and uHealth 9 (5) (2021)
Andreas Fritsche, Robert Wagner, Martin Heni, Kostantinos Kantartzis, Jürgen Machann, Fritz Schick, Rainer Lehmann, Andreas Peter, Corinna Dannecker, Louise Fritsche, Vera Valenta, Renate Schick, Peter Paul Nawroth, Stefan Kopf, Andreas F H Pfeiffer, Stefan Kabisch, Ulrike Dambeck, Michael Stumvoll, Matthias Blüher, Andreas L Birkenfeld, Peter Schwarz, Hans Hauner, Julia Clavel, Jochen Seißler, Andreas Lechner, Karsten Müssig, Katharina Weber, Michael Laxy, Stefan Bornstein, Annette Schürmann, Michael Roden, Martin Hrabě de Angelis, Norbert Stefan, Hans-Ulrich Häring
Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS). Diabetes 70 (12) (2021)
Lina Hui Ying Lau, Jana Nano, Alexander Cecil, Florian Schederecker, Wolfgang Rathmann, Cornelia Prehn, Tanja Zeller, Andreas Lechner, Jerzy Adamski, Annette Peters, Barbara Thorand
Cross-sectional and prospective relationships of endogenous progestogens and estrogens with glucose metabolism in men and women: a KORA F4/FF4 Study. BMJ open diabetes research & care 9 (1) (2021)
Vanessa Sacco, Barbara Rauch, Christina Gar, Stefanie Haschka, Anne L Potzel, Stefanie Kern-Matschilles, Friederike Banning, Irina Benz, Mandy Meisel, Jochen Seissler, Andreas Lechner
Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19. PloS one 15 (11) (2020)
Christina Gar, Stefanie J Haschka, Stefanie Kern-Matschilles, Barbara Rauch, Vanessa Sacco, Cornelia Prehn, Jerzy Adamski, Jochen Seissler, Nicolai J Wewer Albrechtsen, Jens Juul Holst, Andreas Lechner
The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels. Diabetologia 64 (3) (2020)
F Banning, M Rottenkolber, I Freibothe, J Seissler, Andreas Lechner
Insulin secretory defect in familial partial lipodystrophy Type 2 and successful long-term treatment with a glucagon-like peptide 1 receptor agonist. Diabetic medicine : a journal of the British Diabetic Association 34 (12) (2018)